Diabetes, Vol 41, Issue 4 548-551, Copyright © 1992 by American Diabetes Association

ARTICLES

Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus

MJ Rowley, IR Mackay, QY Chen, WJ Knowles and PZ Zimmet
Centre for Molecular Biology and Medicine, Monash University, Clayton, Australia.

Insulin-dependent diabetes mellitus (IDDM) is marked by circulating antibodies to a 64,000-M(r) islet cell antigen identified as glutamic acid decarboxylase (GAD). We describe a radioimmunoprecipitation assay with GAD isolated from pig brain. The sera tested were from 80 patients with IDDM including 26 with disease of recent onset and 54 with disease of longer duration (3-42 yr), 20 with non-insulin-dependent diabetes mellitus (NIDDM), and 55 nondiabetic subjects. Conventional assays for islet cell cytoplasmic antibodies were performed concurrently. The level of antibody in serum was expressed in units based on percentage reactivity of a standard reference serum. The frequency of antibody to GAD in IDDM was 69% in short-duration cases and 59% in long-duration cases. The latter was substantially higher than the frequency of islet cell cytoplasmic antibody. Antibodies to GAD were elevated (means +/- 3 SD) in 5% NIDDM cases and in none of the nondiabetic subjects. A simple laboratory test with a defined autoantigen has substantial implications for population screening and early diagnosis of IDDM and for better understanding of its pathogenesis.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. S. Hampe, R. Nalini, M. R. Maldonado, T. R. Hall, G. Garza, D. Iyer, and A. Balasubramanyam Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with {beta}-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 462 - 467. [Abstract] [Full Text] [PDF]

				I. Vauhkonen, L. Niskanen, M. Knip, L. M. Mykkanen, S. Haffner, M. Uusitupa, and M. Laakso Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults Eur. J. Endocrinol., August 1, 2005; 153(2): 265 - 273. [Abstract] [Full Text] [PDF]

				B. Zinman, S. E. Kahn, S. M. Haffner, M. C. O'Neill, M. A. Heise, M. I. Freed, and ADOPT Study Group* Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe Diabetes, December 1, 2004; 53(12): 3193 - 3200. [Abstract] [Full Text] [PDF]

				N. Allaman-Pillet, J. Storling, A. Oberson, R. Roduit, S. Negri, C. Sauser, P. Nicod, J. S. Beckmann, D. F. Schorderet, T. Mandrup-Poulsen, et al. Calcium- and Proteasome-dependent Degradation of the JNK Scaffold Protein Islet-brain 1 J. Biol. Chem., December 5, 2003; 278(49): 48720 - 48726. [Abstract] [Full Text] [PDF]

				C. S. Hampe, I. Kockum, M. Landin-Olsson, C. Torn, E. Ortqvist, B. Persson, O. Rolandsson, J. Palmer, and A. Lernmark GAD65 Antibody Epitope Patterns of Type 1.5 Diabetic Patients Are Consistent With Slow-Onset Autoimmune Diabetes Diabetes Care, August 1, 2002; 25(8): 1481 - 1482. [Full Text]

				P. Vague and L. Nguyen Rationale and Methods for the Estimation of Insulin Secretion in a Given Patient: From Research to Clinical Practice Diabetes, February 1, 2002; 51(90001): S240 - 244. [Abstract] [Full Text] [PDF]

				O. Pinhas-Hamiel and P. Zeitler The Importance of a Name N. Engl. J. Med., May 6, 1999; 340(18): 1418 - 1421. [Full Text] [PDF]

				M. Falcone, J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick B Lymphocytes Are Crucial Antigen-Presenting Cells in the Pathogenic Autoimmune Response to GAD65 Antigen in Nonobese Diabetic Mice J. Immunol., August 1, 1998; 161(3): 1163 - 1168. [Abstract] [Full Text] [PDF]